Clinical Trials

All trials at Texas Heart Institute must protect patient safety first and foremost.

Our investigators carefully follow protocols designed to maximize benefits and reduce risks.

Our trials are reviewed and monitored by independent Institutional Review Boards (IRBs) and, if required, the Food and Drug Administration (FDA) to ensure patient safety and regulatory compliance.

Our clinical trials have strict eligibility requirements that investigators must follow when enrolling study participants.

Texas Heart Institute provides eligible patients with an informed consent process.  During this process, patients can ask questions and receive study information before deciding to participate in a clinical trial.

A patient’s participation in a clinical trial is always voluntary and the patient can stop participation any time.

If you are considering a clinical trial at Texas Heart Institute, we encourage you to contact us.

Here are some questions you may want to ask:

• What is being studied?
• What tests and treatments will I receive?
• How long will the trial last?
• Are there side effects?
• Who do I contact with problems or questions?
• How often will I return for follow-up visits? Where do I go?
• Will I have to stay in the hospital?
• Are there costs to me or my insurance to participate in this study?
• Will I be able to see my own doctor? Who will oversee my care while I participate?
• Who do I contact if I want to leave the clinical trial?

To learn more about the clinical trials currently available at Texas Heart Institute, visit our Clinical Trials page or call or email.

You can visit ClinicalTrials.gov for an extensive list of privately and publicly funded clinical studies on a wide range of diseases and conditions.

The US Department of Health & Human Services Office of Human Subjects Research Protections (OHRP) created a series of short, informational videos to help potential participants understand how research works.

To learn more information about clinical trials from a patient’s perspective, you can visit the National Heart, Lung, and Blood Institute’s “About Clinical Trials” webpage or the FDA patient education webpage on clinical trials.